Document is current
Any future updates will be listed below
-
Authors
Kietsiriroje, Noppadol https://orcid.org/0000-0002-5076-4450
Shah, Hanya
Zare, Marios
O’Mahoney, Lauren L. https://orcid.org/0000-0002-2786-3290
West, Daniel J. https://orcid.org/0000-0003-2246-4925
Pearson, Sam M.
Ajjan, Ramzi A. https://orcid.org/0000-0002-1636-3725
Campbell, Matthew D. https://orcid.org/0000-0001-5883-5041
- License Information
-
More Information
Article History
Received: 12 July 2022
Accepted: 1 December 2022
First Online: 10 December 2022
Declarations
:
: NK, HS, MZ, NS, SMP, LLO, and DJW have no conflict of interest to be declared. MDC reports personal fees, grants, and other, from Abbott Diabetes Care, Eli Lilly, AstraZeneca, NovoNordisk, Boehringer Ingelheim and AGADA, outside the submitted work, and is a company director and has a financial interest in Insutiv, T1D One Life Ltd. RAA reports grants, personal fees, and other from Abbott Diabetes Care, personal fees from AstraZeneca, personal fees from Boehringer Ingelheim, personal fees from Eli Lilly, personal fees from Menarini Pharmaceuticals, and personal fees from NovoNordisk, outside the submitted work.
